hnologies, products or applications, or
the Company's business initiatives will take longer, cost more or produce
lower benefits than anticipated, (c) the possibility that application of or
compliance with laws, court rulings, regulations, certifications or other
requirements or standards may delay or prevent new product introductions,
affect the production and marketing of existing products, or otherwise
affect Company performance, results, or value, (d) the potential of
international unrest or effects of fluctuations in currencies, tax
assessments or rates, raw material costs, benefit or retirement plan costs,
or other regulatory compliance costs, (e) the possibility of reduced
demand, or reductions in the rate of growth in demand, for the Company's
products and services, and (f) the possibility that anticipated cost
savings may not be achieved, or that transition, labor, competition,
timing, execution, regulatory, governmental, executive transition or other
issues or risks associated with the matters described in this release, or
the referenced conference call, may adversely impact Company performance,
results, or value.
STERIS Corporation
Consolidated Condensed Statements of Income
(In thousands, except per share data)
Three Months Ended Nine Months Ended
December 31, December 31,
2007 2006 2007 2006
(Unaudited)(Unaudited)(Unaudited)(Unaudited)
Revenues $313,974 $298,967 $889,920 $847,570
Cost of revenues 183,775 171,266 517,339 487,733
Gross profit 130,199 127,701 372,581 359,837
Operating expenses:
Selling, general, and
administrative 85,612 82,594 260,100 243,789
Restructuring expense
'/>"/>
SOURCE STERIS Corporation Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 10 11 Related medicine news :1.
STERIS Corporation Board of Directors Names Walter M. Rosebrough Jr. President and Chief Executive Officer2.
STERIS Corporation Announces Date of Fiscal 2008 Second Quarter Earnings Release and Conference Call3.
STERIS Corporation Announces Fiscal 2008 Second Quarter Results4.
STERIS Corporation Announces Date of Fiscal 2008 Third Quarter Earnings Release and Conference Call5.
STERIS Corporation Declares Regular Quarterly Dividend6.
The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products7.
Brooke Franchise Corporation Announces Selected July Results8.
MedThink Communications Retained by NanoBio Corporation9.
EaglePicher Corporation Completes Transaction to Sell EaglePicher Boron, LLC to Ceradyne, Inc. for $69 Million10.
Dana Corporation, Inc. Enters Into Settlement Agreement With Dana Retiree Committee11.
Memry Corporation Announces Fiscal Fourth Quarter and 2007 Year End Earnings Release and Conference Call